Biomarker analysis of pivotal phase II study of oral panobinostat (PAN) in relapsed/refractory Hodgkin lymphoma (HL) patients following autologous stem cell transplant (ASCT).
暂无分享，去创建一个
A. Younes | R. Bugarini | D. Ritchie | A. Engert | P. Neeson | A. Sureda | P. Savage | A. Hsu | J. Gallagher | C. Le Corre | A. Shen | D. Williams | M. Li | S. Harrison